C.F.R. homeSearch C.F.R.
C.F.R.Title 21Chapter I—Food and Drug Administration, Department of Health and Human ServicesSubchapter H—Medical DevicesPart 803—Medical Device ReportingSubpart E—Manufacturer Reporting Requirements

21 C.F.R. § 803.53 (2026)

If I am a manufacturer, in which circumstances must I submit a 5-day report?

Edition and currency
eCFR text as of Sept. 29, 2026. The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTeCFR text as of Sept. 29, 2026 cited 2006–2021 8citing cases
At a glance

Courts have cited this section in 8 opinions since 2006, 1 of them in the last five years.

You must submit a 5-day report to us with the information required by § 803.52 in accordance with the requirements of § 803.12(a) no later than 5 work days after the day that you become aware that:

(a) An MDR reportable event necessitates remedial action to prevent an unreasonable risk of substantial harm to the public health. You may become aware of the need for remedial action from any information, including any trend analysis or

(b) We have made a written request for the submission of a 5-day report. If you receive such a written request from us, you must submit, without further requests, a 5-day report for all subsequent events of the same nature that involve substantially similar devices for the time period specified in the written request. We may extend the time period stated in the original written request if we determine it is in the interest of the public health.

The 8 cases that cite 21 C.F.R. § 803.53 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENRiegel v. Medtronic, Inc., 451 F.3d 104 (2d Cir. 2006).
cites § 803.53 2×cited by 104 cases
Where it cites § 803.53
“21 C.F.R. § 803.53 . 11 the safety and effectiveness of the device.”
The case’s holding
State common law tort claims alleging liability based on a medical device's adherence to FDA premarket approval standards are preempted by the Medical Device Amendments.
Later courts cite it for
“an expert opinion requires some explanation as to how the expert came to his conclusion and what methodologies or evidence substantiate that conclusion.” · 26 citing courts
2
GREENIn re Medtronic, Inc. Sprint Fidelis Leads Prods. Liab. Litig., 592 F. Supp. 2d 1147 (D. Minn. 2009).
cites § 803.53 1×cited by 84 cases
Where it cites § 803.53
“50 and 21 C.F.R. § 803.53 , regulations that were promulgated by the FDA in accordance with the FDCA.”
The case’s holding
State-law claims are preempted if they impose requirements different from or in addition to federal requirements established through the pre-market approval process for medical devices.
Later courts cite it for
“an adequately pleaded claim that a specific device was not manufactured in accordance with its pma specifications can survive preemption.” · 3 citing courts
cites § 803.53 1×cited by 14 cases
Where it cites § 803.53
“21 C.F.R. § 803.53 . The FDA may withdraw approval from a device if it determines, based on existing or new information, that "such device is unsafe or ineffective under the conditions of use prescribed, recommended, or suggested in the labeling thereof.”
The case’s holding
State claims for medical devices that would require finding an FDA-approved device unreasonably dangerous are expressly preempted, while claims premised on violations of federal requirements survive preemption.
Later courts cite it for
“a claim for punitive damages is derivative and therefore survives if the plaintiff's underlying claims that support it survive.” · 2 citing courts
4
GREENPinsonneault v. St. Jude Med., Inc., 953 F. Supp. 2d 1006 (D. Minn. 2013).
cites § 803.53 1×cited by 13 cases
Where it cites § 803.53
“50 was an attempt to enforce the MDA, ( 2011 WL 1485601 at *3), plaintiffs in this case rely on the same regulation relating to the MDR reporting requirements to support their failure-to-warn claim.”
5
GREENRowe v. Mentor Worldwide, LLC, 297 F. Supp. 3d 1288 (M.D. Fla. 2018).
cites § 803.53 1×cited by 4 cases
Summary
No passage or summary on file for this case yet.
6
NO FLAGGowin v. Smith & Nephew, Inc., No. 1:17-cv-00949 (D. Md. Aug. 14, 2019).
cites § 803.53 1×cited by 0 casesunknown
Where it cites § 803.53
“50 , and to report these findings to the FDA within five days, 21 C.F.R. § 803.53 . If manufacturers want to make changes to a PMA approved device, they must submit an application for “supplemental premarket approval” to the FDA.”
7
NO FLAGMilanesi v. C.R. Bard, Inc., No. 2:18-cv-01320 (S.D. Ohio Dec. 13, 2021).
cites § 803.53 1×cited by 0 casesunknown
Where it cites § 803.53
“” 21 C.F.R. § 803.53 . This “adverse event information” includes any information that “reasonably suggests” that a manufacturer’s device “[m]ay have caused or contributed to a death or serious injury” or “[h] as malfunctioned and this device or a similar device that [they]…”
8
NO FLAGGowin v. Smith & Nephew, Inc., No. 1:17-cv-00949 (D. Md. Aug. 5, 2019).
cites § 803.53 1×cited by 0 casesunknown
Where it cites § 803.53
“50 , and to report these findings to the FDA within five days, 21 C.F.R. § 803.53 . If manufacturers want to make changes to a PMA approved device, they must submit an application for “supplemental premarket approval” to the FDA.”

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
200620132021

One bar per year. Tallest: 2 cases in 2018. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
D. Md.3D. Minn.22d Cir.1M.D. Fla.1S.D. Ohio1
By subsection

Courts have not cited this section by subsection, so its cases are not split up here. The Leading cases tab lists the cases that cite it most heavily.

Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: eCFR text as of Sept. 29, 2026. Syfert holds no earlier or later version of this section.

C.F.R. Home  |  Search C.F.R.  |  Search cases for this section  |  syfert.com